In this news, we discuss the Qatar signs deal to buy Moderna COVID-19 vaccine.
DUBAI (Reuters) – Qatar has signed an agreement with drugmaker Moderna Inc MRNA.O to purchase its potential COVID-19 vaccine as soon as it is approved and released to the world, the agency said on Sunday. QNA official press citing a health official.
There are no internationally approved vaccines yet, but several are under advanced testing, including those from Pfizer Inc. PFE.N, Johnson & Johnson JNJ.N, and Moderna.
“Early negotiation and securing a number of agreements increase our chances of getting sufficient quantities of vaccine quickly,” said Abdullatif al-Khal, chairman of a national COVID-19 health group and official. of infectious diseases at Hamad Medical Corporation.
He did not say how many doses Doha was asking for. Earlier this month, al-Khal said Qatar had signed an agreement with Pfizer and BioNTech to supply Qatar with their vaccines.
Moderna said last month it was on track to produce 20 million doses of its vaccine by the end of the year, while maintaining its goal of preparing 500 million to 1 billion doses in 2021.
The US group is also working with the Swiss group Lonza AG to scale up manufacturing and production of its potential COVID-19 vaccine to supply markets outside the United States.
Reporting by Yousef Saba; Written by Ghaida Ghantous; Edited by Andrew Heavens
Original © Thomson Reuters
Originally posted 2020-10-25 13:36:10.